James H Stanker Processa Pharmaceuticals, Inc. (PCSA) insider trading activity

James H Stanker is Chief Financial Officer of Processa Pharmaceuticals, Inc.. Currently has a direct ownership of 6,482 shares of PCSA, which is worth approximately $5,574. The most recent transaction as insider was on Jul 10, 2024, when has been sold 282 shares (Common Stock) at a price of $1.71 per share, resulting in proceeds of $482. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 6.48K

0% 3M change

93.47% 12M change

Total Value Held $5,574

James H Stanker Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 10 2024	SELL Payment of exercise price or tax liability	$482 $1.71 p/Share	282 Reduced 4.17%	6,482 Common Stock
Jul 10 2024	BUY Exercise of conversion of derivative security	-	644 Added 8.69%	6,764 Common Stock
Apr 05 2024	SELL Payment of exercise price or tax liability	$1,445 $2.79 p/Share	518 Reduced 7.8%	6,120 Common Stock
Apr 05 2024	BUY Exercise of conversion of derivative security	-	1,675 Added 20.15%	6,638 Common Stock
Jan 01 2024	SELL Payment of exercise price or tax liability	$1,445 $2.79 p/Share	518 Reduced 7.8%	6,120 Common Stock
Jan 01 2024	BUY Exercise of conversion of derivative security	-	1,675 Added 20.15%	6,638 Common Stock
Oct 12 2023	BUY Grant, award, or other acquisition	$4,950 $0.33 p/Share	15,000 Added 13.13%	99,250 Common Stock
Oct 10 2023	BUY Grant, award, or other acquisition	$5,400 $0.24 p/Share	22,500 Added 21.08%	84,250 Common Stock
Feb 09 2023	BUY Grant, award, or other acquisition	$10,000 $0.8 p/Share	12,500 Added 16.84%	61,750 Common Stock
Aug 05 2022	SELL Payment of exercise price or tax liability	$7,805 $3.17 p/Share	2,462 Reduced 4.76%	49,250 Common Stock
Aug 05 2022	BUY Exercise of conversion of derivative security	-	7,601 Added 12.82%	51,712 Common Stock
Aug 05 2021	BUY Grant, award, or other acquisition	-	7,601 Added 14.7%	44,111 Common Stock
Jun 21 2021	BUY Open market or private purchase	$6,810 $6.81 p/Share	1,000 Added 2.67%	36,510 Common Stock
Oct 01 2020	BUY Open market or private purchase	$12,600 $2.1 p/Share	6,000 Added 11.27%	47,248 Common Stock

JHS

James H Stanker

Chief Financial Officer

Hanover, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCSA shares.

Notify only if

Value

Insider Trading

Get notified when an Processa Pharmaceuticals, Inc. insider buys or sells PCSA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Processa Pharmaceuticals, Inc.

Track Activities on PCSA

Account